Source · study

Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea

Primary source

Publisher:: Journal of Cosmetic Dermatology (Berardesca E, 2012)
Source type:: Journal · study
Last checked:: 2026-11-10
URL:: https://doi.org/10.1111/j.1473-2165.2011.00598.x

Pages that cite it

Evidence: In a 42-subject randomized, multicenter, double-blind, placebo-controlled pilot trial, a cream containing 5% potassium azeloyl diglycinate and 1% hydroxypropyl chitosan applied twice daily for 28 days reduced facial erythema in rosacea, measured both with a Mexameter and by clinical grading, compared with placebo.